These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18930329)

  • 41. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
    Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
    Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate.
    Laharie D; Zerbib F; Adhoute X; Boué-Lahorgue X; Foucher J; Castéra L; Rullier A; Bertet J; Couzigou P; Amouretti M; de Lédinghen V
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1621-8. PubMed ID: 16696812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
    Poynard T; Halfon P; Castera L; Charlotte F; Le Bail B; Munteanu M; Messous D; Ratziu V; Benhamou Y; Bourlière M; De Ledinghen V;
    Aliment Pharmacol Ther; 2007 Mar; 25(6):733-9. PubMed ID: 17311607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years.
    Roulot D; Costes JL; Buyck JF; Warzocha U; Gambier N; Czernichow S; Le Clesiau H; Beaugrand M
    Gut; 2011 Jul; 60(7):977-84. PubMed ID: 21068129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.
    Poynard T; de Ledinghen V; Zarski JP; Stanciu C; Munteanu M; Vergniol J; France J; Trifan A; Lenaour G; Vaillant JC; Ratziu V; Charlotte F;
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):455-63. PubMed ID: 22959098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS; Weiss DG; Paronetto F;
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features.
    Mathurin P; Beuzin F; Louvet A; Carrié-Ganne N; Balian A; Trinchet JC; Dalsoglio D; Prevot S; Naveau S
    Aliment Pharmacol Ther; 2007 May; 25(9):1047-54. PubMed ID: 17439505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.
    Myers RP; Crotty P; Pomier-Layrargues G; Ma M; Urbanski SJ; Elkashab M
    Liver Int; 2010 Nov; 30(10):1471-80. PubMed ID: 20807336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease.
    Mahadeva S; Mahfudz AS; Vijayanathan A; Goh KL; Kulenthran A; Cheah PL
    J Dig Dis; 2013 Nov; 14(11):604-10. PubMed ID: 23859493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
    Miyaaki H; Ichikawa T; Nakao K; Yatsuhashi H; Furukawa R; Ohba K; Omagari K; Kusumoto Y; Yanagi K; Inoue O; Kinoshita N; Ishibashi H; Yano M; Eguchi K
    Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Shear wave elastography in the evaluation of liver fibrosis in children.
    Tutar O; Beşer ÖF; Adaletli I; Tunc N; Gulcu D; Kantarci F; Mihmanli I; Cokugras FC; Kutlu T; Ozbay G; Erkan T
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):750-5. PubMed ID: 24552673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study.
    Janssens F; de Suray N; Piessevaux H; Horsmans Y; de Timary P; Stärkel P
    J Clin Gastroenterol; 2010 Sep; 44(8):575-82. PubMed ID: 20104185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.
    Petta S; Vanni E; Bugianesi E; Di Marco V; Cammà C; Cabibi D; Mezzabotta L; Craxì A
    Liver Int; 2015 May; 35(5):1566-73. PubMed ID: 24798049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease.
    Michalak S; Rousselet MC; Bedossa P; Pilette C; Chappard D; Oberti F; Gallois Y; Calès P
    J Pathol; 2003 Sep; 201(1):55-62. PubMed ID: 12950017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
    Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.
    Chow JC; Wong GL; Chan AW; Shu SS; Chan CK; Leung JK; Choi PC; Chim AM; Chan HL; Wong VW
    J Gastroenterol Hepatol; 2019 Jan; 34(1):241-248. PubMed ID: 29890010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C.
    Zvibel I; Halfon P; Fishman S; Penaranda G; Leshno M; Or AB; Halpern Z; Oren R
    Liver Int; 2009 Feb; 29(2):208-12. PubMed ID: 18694404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients.
    Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Duarte-Rojo A; Wong D; Beaton M; Levstik M; Crotty P; Elkashab M
    Hepatology; 2012 Jan; 55(1):199-208. PubMed ID: 21898479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.